Assessment of diffuse Lewy body disease by 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET)

BMC Nuclear Medicine

Volumn 3, Issue , 2003, Pages 1-4

  Mirzaei, Siroos ^a   Knoll, Peter ^a   Koehn, Horst ^a   Bruecke, Thomas ^b  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^b NONE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE;

AGED; ARTICLE; BRAIN CORTEX; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; GLUCOSE METABOLISM; HUMAN; IMAGE ANALYSIS; MALE; POSITRON EMISSION TOMOGRAPHY; SCINTILLATION CAMERA; SCORING SYSTEM; SENSORIMOTOR CORTEX; TISSUE DISTRIBUTION;

EID: 0142203022     PISSN: 14712385     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2385-3-1     Document Type: Article

References (27)

1. Byne EJ, Lennox G and Godwin-Austen R Diffuse Lewy body disease: clinical features in 15 cases. J Neurol Neurosurg Psychiatry 1989, 52:709-717
2. Hansen L, Salmon D, Galasko D, Masliah E, Katzman R, DeTeresa R, Thal L, Pay MM, Hofstetter R and Klauber M The Lewy body variant of Alzheimer's disease: a pathological and clinical entity. Neurology 1990, 40:1-8
3. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA and Perry RH Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996, 47:1113-1124
4. Lewy FH Paralysis agitans. In: Pathologische Anantomie. Handbuch der Neurologie (Edited by: Lewandowsky M) Berlin: Springer Verlag 1912, 920-933
5. Hansen LA and Noville RL Lewy body disease. Curr Opin Neurol Neurosurg 1992, 5:889-894
6. Ransmayr G, Wenning GK, Seppi K, Jellinger K and Poewe W Demenz mit Lewy-Körperchen. Nervenarzt 2000, 71:929-935
7. McKhann G, Drachman D, Folstein M, Katzman R, Price D and Stadlan EM Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984, 34:939-944
8. Soininen H, Laulumaa V, Helkala EL, Hartikainen P and Riekkinen PJ Extrapyramidal signs in Alzheimer's disease: a 3-year follow-up study. J Neural Transm Park Dis Dement Sect 1992, 4:107-119
9. Foerstl H, Burns A, Luther P, Cairns N and Levy R The Lewy body variant of Alzheimer's disease: clinical and pathological findings. Br J Psychiatry 1993, 162:385-392
10. Gnanalingham KK, Byrne EJ, Thornton A, Sambrook MA and Bannister P Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's diseases. J Neurol Neurosurg Psychiatry 1997, 62:243-252
11. Costa DC, Pilowsky LS and Ell PJ Nuclear Medicine in neurology and psychiatry. Lancet 1999, 354:1107-11
12. Goodwin GM Functional imaging, affective disorder and dementia. Br Med Bull 1996, 52:495-512
13. Neary D, Snowden JS, Shields RA, Burjan AWI and Northen B Single photon emission tomography using 99mTc-HMPAO in the investigation of dementia. J Neurol Neurosurg Psychiatry 1987, 50:1101-1109
14. Waldemar G, Bruhn P, Kristensen M, Johnsen A, Paulson OB and Lassen NA Heterogeneity of neocortical cerebral blood flow deficits in dementia of the Alzheimer type: a 99mTc-d,1-HMPAO SPECT study. J Neurol Neurosurg Psychiatry 1994, 57:285-295
15. Donnemiller E, Heilmann J, Wenning GK, Berger W, Decristoforo C, Moncayo R, Poewe W and Ransmayr G Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 123I-β-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease. Eur J Nucl Med 1997, 24:320-325
16. Mirzaei S, Knoll P and Köhn H Comparison of different methods for attenuation correction in brain PET. Nuklearmedizin 2000, 39(6):N95
17. Albin RL, Minoshima S, D'Amato CJ, Frey KA, Kuhl DA and Sima AA Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease. Neurology 1996, 47:462-466
18. Gibb WR, Luthert PJ, Janota I and Lantos PL Cortical Lewy body dementia: clinical features and classification. J Neurol Neurosurg Psychiatry 1989, 52:185-192
19. Kosaka K, Yoshimura M, Ikeda K and Budka H Diffuse type of Lewy disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree - a new disease? Clin Neuropathol 1984, 3:185-192
20. Lebert F, Souliez L and Pasquier F Tacrine and symptomatic treatment in Lewy body dementia. In: Dementia with Lewy bodies. Clinical, Pathological and Treatment Issues (Edited by: Perry R, McKeith I, Perry E) Cambridge: Cambridge University Press 1996, 439-448
21. Walker Z, Costa DC, Ince P, McKeith IG and Katona CLE In-vivo demonstration of dopaminergic degeneration in dementia with Lewy bodies. The Lancet 1999, 354:646-647
22. 123I-IBZM SPET. Eur J Nucl Med 1997, 24:609-614
23. Walker Z, Costa DC, Walker RW, Shaw K, Gacinovic S, Stevens T, Livingston G, Ince P, McKeith IG and Katona CL Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic Presynaptic ligand. J Neurol Neurosurg Psychiatry 2002, 73:134-140
24. Suzuki M, Desmond TJ, Albin RL and Frey KA Striatal monoaminergic terminals in Lewy body and Alzheimer's dementias. Ann Neurol 2002, 51:767-771
25. Minoshima S, Foster NL, Sima AA, Frey KA, Albin RL and Kuhl DE Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann Neurol 2001, 50:358-365
26. Brunberg J, Frey K, Horton J and Kuhl Crossed cerebellar diaschisis: occurence and resolution demonstrated with PET during carotid temporary ballon occlusion. AKNR 1992, 13:58-61
27. Levine DN, Lee JM and Fischer CM The visual variant of Alzheimer's disease: a clinicopathologic case study. Neurology 1993, 43:305-313